Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Indian doctors report highly successful stem cell transplants for sickle cell disease in children, with up to 96% success using matched siblings.
Doctors at Fortis Memorial Research Institute in Gurugram, India, report a major advance in curing children with Sickle Cell Disease (SCD) using stem cell transplants, based on a decade-long study of 100 pediatric cases.
The research, published in Haemoglobin, found an overall survival rate of nearly 87%, with 96% success in matched sibling donor transplants and 78% in half-matched family donor transplants—among the best globally.
The team achieved these outcomes through advanced protocols that reduce complications like graft-versus-host disease, including reduced-toxicity conditioning and post-transplant cyclophosphamide.
Early intervention before organ damage occurred was key to success.
The findings demonstrate that high-quality, scalable stem cell transplants are feasible in resource-limited settings, offering hope for children in India and sub-Saharan Africa, where SCD is most prevalent.
Experts stress the need for donor registries, early diagnosis, and strong post-transplant care to expand access to this life-saving treatment worldwide.
Los médicos indios informan de trasplantes de células madre de gran éxito para la enfermedad de células falciformes en niños, con hasta un 96% de éxito utilizando hermanos emparejados.